Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
28.52
+0.36 (1.28%)
At close: May 4, 2026, 4:00 PM EDT
28.57
+0.05 (0.18%)
After-hours: May 4, 2026, 4:04 PM EDT

Immunocore Holdings Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
400.02310.2249.43174.3636.48
Revenue Growth (YoY)
28.95%24.37%43.05%377.91%-11.39%
Cost of Revenue
10.175.913.142.73-
Gross Profit
389.84304.29246.29171.6336.48
Selling, General & Admin
328.35313.54302.99236.44110.82
Research & Development
550.18442.38328.53209.8100.25
Other Operating Expenses
---0-
Total Operating Expenses
878.53755.91631.51446.24211.07
Operating Income
-45.35-70.46-59.65-51.71-174.59
Interest Income
52.6865.0236.257.570.07
Interest Expense
-37.3-49.26-13.31-14.71-5.57
Other Non-Operating Income (Expense)
21.9410.75-14.0712.480.22
Total Non-Operating Income (Expense)
37.3226.518.875.33-5.29
Pretax Income
-32.24-60.18-59.94-53.41-179.88
Provision for Income Taxes
-7.3711.085.6-11.66-
Net Income
-35.51-51.09-55.29-52.54-180.03
Net Income to Common
-35.51-51.09-55.29-52.54-180.03
Shares Outstanding (Basic)
5050494642
Shares Outstanding (Diluted)
5050494642
Shares Change (YoY)
0.71%2.25%6.94%7.59%60.19%
EPS (Basic)
-0.71-1.02-1.13-1.15-4.24
EPS (Diluted)
-0.71-1.02-1.13-1.15-4.24
Shares Outstanding
50.6950.0649.7348.0943.86
Free Cash Flow
-15.0520.89-2.49-51.41-144.49
Free Cash Flow Per Share
-0.300.42-0.05-1.12-3.40
Gross Margin
97.46%98.09%98.74%98.44%100.00%
Operating Margin
-11.34%-22.71%-23.91%-29.66%-478.53%
Profit Margin
-10.32%-22.42%-21.00%-28.60%-493.03%
FCF Margin
-3.76%6.73%-1.00%-29.49%-396.04%
EBITDA
-35.33-52.64-48.81-38.96-167
EBITDA Margin
-8.83%-16.97%-19.57%-22.34%-457.72%
EBIT
-45.35-70.46-59.65-51.71-174.59
EBIT Margin
-11.34%-22.71%-23.91%-29.66%-478.53%
Effective Tax Rate
22.85%-18.41%-9.35%21.83%0.00%
Updated Feb 25, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q